Proteome Sciences. AGM Statement.

This might give the shadow of a ghost of an idea of a value for Intronn

AstraZeneca buys cancer researcher KuDOS Pharma for 210 mln usd UPDATE

LONDON (AFX) - AstraZeneca PLC moved to strengthen its ability to produce
new cancer treatments with the 210 mln usd acquisition of privately-owned
oncology researcher KuDOS Pharmaceuticals.
The UK biotechnology company, founded by a Cambridge University professor,
is focused on discovering and developing oncology therapies based on enzymes
that can trigger the repair of damaged DNA. Full story here:


PS. Many thanks to the contributors who have made this board a memorable read throughout the year, all the best for the festive season, and good health and fortune to all in the year to come, from a deep-frozen SW France.